Risks of Noncompliance A wellness center that offers injectable NAD+ or glutathione without meeting drug requirements can face: FDA warning letters State medical board actions State pharmacy board actions Product seizure Civil penalties FDA has issued recalls of injectable NAD+ products for contamination
As nearly all former GLP-1 users will attest, the weight just bounces right back
10.1523/JNEUROSCI.5369-03.2004 J
Parenteral anticoagulants and direct oral anticoagulant monitoring: guidance from ISTH
Compounded GLP-1 medications may not be right for everyone and may have certain side effects, such as nausea, vomiting, diarrhea, constipation, abdominal pain, or reduced appetite
Additionally, 45% of global sales of pharmaceuticals are attributed to NSAIDs and ibuprofen being a major contributor (Schmidt and Redshaw, 2015)